- Home
- ITOS vs AUDC Comparison
ITOS vs AUDC Comparison
Compare ITOS & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- AUDC
- Stock Information
- Founded
- ITOS 2011
- AUDC 1992
- Country
- ITOS United States
- AUDC Israel
- Employees
- ITOS N/A
- AUDC N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- AUDC Telecommunications Equipment
- Sector
- ITOS Health Care
- AUDC Utilities
- Exchange
- ITOS Nasdaq
- AUDC Nasdaq
- Market Cap
- ITOS 270.7M
- AUDC 279.1M
- IPO Year
- ITOS 2020
- AUDC 1999
- Fundamental
- Price
- ITOS $6.70
- AUDC $8.44
- Analyst Decision
- ITOS Strong Buy
- AUDC Buy
- Analyst Count
- ITOS 3
- AUDC 3
- Target Price
- ITOS $25.67
- AUDC $11.67
- AVG Volume (30 Days)
- ITOS 553.7K
- AUDC 109.7K
- Earning Date
- ITOS 04-28-2025
- AUDC 05-06-2025
- Dividend Yield
- ITOS N/A
- AUDC 2.13%
- EPS Growth
- ITOS N/A
- AUDC 57.57
- EPS
- ITOS N/A
- AUDC 0.56
- Revenue
- ITOS $35,000,000.00
- AUDC $242,474,000.00
- Revenue This Year
- ITOS N/A
- AUDC $5.11
- Revenue Next Year
- ITOS $31.74
- AUDC $3.81
- P/E Ratio
- ITOS N/A
- AUDC $15.02
- Revenue Growth
- ITOS 177.89
- AUDC N/A
- 52 Week Low
- ITOS $4.80
- AUDC $7.70
- 52 Week High
- ITOS $18.75
- AUDC $12.72
- Technical
- Relative Strength Index (RSI)
- ITOS 49.45
- AUDC 35.54
- Support Level
- ITOS $6.58
- AUDC $8.01
- Resistance Level
- ITOS $7.80
- AUDC $9.84
- Average True Range (ATR)
- ITOS 0.51
- AUDC 0.31
- MACD
- ITOS -0.03
- AUDC -0.06
- Stochastic Oscillator
- ITOS 32.10
- AUDC 23.50
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.